Literature DB >> 15537510

The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?

David W Desmond1.   

Abstract

The concept of Vascular Cognitive Impairment (VCI) encompasses patients across the entire continuum of cognitive impairment resulting from cerebrovascular disease (CVD), ranging from high-risk patients with no frank cognitive deficit (the "brain-at-risk" stage) through vascular dementia (VaD). There are accepted differences in the neuropsychological profile of patients with Alzheimer's disease (AD) and VaD. In patients with VaD, executive functions that tend to be disproportionately impaired include planning and sequencing, speed of mental processing, performance on unstructured tasks, and attention. Language production may be impaired in patients with VaD but primary language functions otherwise tend to be preserved. Patients with VaD also exhibit significantly more perseverations than patients with AD. Memory impairment is typically evident in patients with AD+CVD but memory impairment may also occur as a primary consequence of stroke in the posterior cerebral artery territory with involvement of the medial temporal lobe, or as a secondary consequence of a cognitive syndrome involving inattention due to primary executive dysfunction. Compared to VaD, patients with AD may exhibit greater deficits in functions (including memory) mediated by posterior cortical structures, such as the temporal and parietal lobes. AD patients exhibit a faster rate of information decay, reduced ability to benefit from cues to facilitate retrieval, and higher frequency of intrusion errors; in addition, certain aspects of language function, such as naming, may exacerbate deficits on verbal memory tasks. AD tends to affect lexicon while VaD tends to affect syntax. When patients with AD exhibit perseverations, they tend to be elicited by tests of semantic knowledge.

Entities:  

Mesh:

Year:  2004        PMID: 15537510     DOI: 10.1016/j.jns.2004.09.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  48 in total

1.  Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.

Authors:  Marcelo Ganzella; Enderson Dias Alves de Oliveira; Daniel Diniz Comassetto; Fernanda Cechetti; Victor Hermes Cereser; Júlia Dubois Moreira; Gisele Hansel; Roberto Farina Almeida; Denise Barbosa Ramos; Yanier Nuñes Figueredo; Debora Guerini Souza; Jean Pierre Oses; Paulo Valdeci Worm; Matilde Achaval; Carlos Alexandre Netto; Diogo Onofre Souza
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

2.  Depression and cognitive function in maintenance hemodialysis patients.

Authors:  Brian T Agganis; Daniel E Weiner; Lena M Giang; Tammy Scott; Hocine Tighiouart; John L Griffith; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2010-07-29       Impact factor: 8.860

Review 3.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

4.  Leisure activities and risk of vascular cognitive impairment in older adults.

Authors:  Joe Verghese; Mindy J Katz; Amy Sanders; Richard B Lipton
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-03-23       Impact factor: 2.680

5.  Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment.

Authors:  Qianhua Zhao; Qihao Guo; Zhen Hong
Journal:  Neurosci Bull       Date:  2013-01-15       Impact factor: 5.203

6.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

7.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

8.  Differences in functional impairment across subtypes of dementia.

Authors:  Tanya Ruff Gure; Mohammed U Kabeto; Brenda L Plassman; John D Piette; Kenneth M Langa
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-12-17       Impact factor: 6.053

9.  Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.

Authors:  Elisabeth C W van Straaten; Danielle Harvey; Philip Scheltens; Frederik Barkhof; Ronald C Petersen; Leon J Thal; Clifford R Jack; Charles DeCarli
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

10.  Metabolic syndrome, brain magnetic resonance imaging, and cognition.

Authors:  Margherita Cavalieri; Stefan Ropele; Katja Petrovic; Aga Pluta-Fuerst; Nina Homayoon; Christian Enzinger; Anja Grazer; Petra Katschnig; Petra Schwingenschuh; Andrea Berghold; Reinhold Schmidt
Journal:  Diabetes Care       Date:  2010-09-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.